A less invasive airway device — called a supraglottic airway device or SAD — was found to safely and effectively…
Marta Figueiredo, PhD
Marta holds a biology degree, a master’s in evolutionary and developmental biology, and a PhD in biomedical sciences from the University of Lisbon, Portugal. She was awarded a research scholarship and a PhD scholarship, and her research focused on the role of several signaling pathways in thymus and parathyroid glands embryonic development. She also previously worked as an assistant professor of an annual one-week embryology course at the University of Lisbon’s Faculty of Medicine.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marta Figueiredo, PhD
The gene therapy Upstaza (eladocagene exuparvovec), formerly PTC-AADC, has been recommended for approval in the European Union for patients,…
Centogene has launched CentoCloud, a cloud-based platform designed to allow decentralized analysis and interpretation of an individual’s genetic…
Researchers have developed and validated new tools to help evaluate health-related quality of life, or HRQoL, in people with…
Delivering the investigational gene therapy PTC-AADC to a specific part of the brain, called the putamen, was found to…
Caregivers of children with aromatic l-amino acid decarboxylase (AADC) deficiency spend the bulk of their days providing care, with most…
People with rare disorders have a worse healthcare experience than those affected by chronic diseases, according to the results of…
PTC Therapeutics has developed and validated tools to help assess health-related quality of life (HRQoL) in people with…
The first wave of COVID-19Â in Europe severely disrupted access to care and raised stress and anxiety in people with…
PTC Therapeutics’ investigational gene therapy PTC-AADC is expected to result in long-term and durable therapeutic benefits in children with…